351 related articles for article (PubMed ID: 11579088)
1. Paraoxonase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein.
Ng CJ; Wadleigh DJ; Gangopadhyay A; Hama S; Grijalva VR; Navab M; Fogelman AM; Reddy ST
J Biol Chem; 2001 Nov; 276(48):44444-9. PubMed ID: 11579088
[TBL] [Abstract][Full Text] [Related]
2. Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids.
Reddy ST; Wadleigh DJ; Grijalva V; Ng C; Hama S; Gangopadhyay A; Shih DM; Lusis AJ; Navab M; Fogelman AM
Arterioscler Thromb Vasc Biol; 2001 Apr; 21(4):542-7. PubMed ID: 11304470
[TBL] [Abstract][Full Text] [Related]
3. The paraoxonase 1, 2 and 3 in humans.
Rajkovic MG; Rumora L; Barisic K
Biochem Med (Zagreb); 2011; 21(2):122-30. PubMed ID: 22135851
[TBL] [Abstract][Full Text] [Related]
4. Evidence for a paraoxonase-independent inhibition of low-density lipoprotein oxidation by high-density lipoprotein.
Graham A; Hassall DG; Rafique S; Owen JS
Atherosclerosis; 1997 Dec; 135(2):193-204. PubMed ID: 9430369
[TBL] [Abstract][Full Text] [Related]
5. Paraoxonase, a cardioprotective enzyme: continuing issues.
Getz GS; Reardon CA
Curr Opin Lipidol; 2004 Jun; 15(3):261-7. PubMed ID: 15166781
[TBL] [Abstract][Full Text] [Related]
6. Rabbit serum paraoxonase 3 (PON3) is a high density lipoprotein-associated lactonase and protects low density lipoprotein against oxidation.
Draganov DI; Stetson PL; Watson CE; Billecke SS; La Du BN
J Biol Chem; 2000 Oct; 275(43):33435-42. PubMed ID: 10931838
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein.
Watson AD; Berliner JA; Hama SY; La Du BN; Faull KF; Fogelman AM; Navab M
J Clin Invest; 1995 Dec; 96(6):2882-91. PubMed ID: 8675659
[TBL] [Abstract][Full Text] [Related]
8. [Paraoxonase: The Universal Factor of Antioxidant Defense in Human Body].
Borovkova EI; Antipova NV; Komeenko TV; Shakhparonov MI; Borovkov IM
Vestn Ross Akad Med Nauk; 2017; 72(1):5-10. PubMed ID: 29308836
[TBL] [Abstract][Full Text] [Related]
9. Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: steps 2 and 3.
Navab M; Hama SY; Anantharamaiah GM; Hassan K; Hough GP; Watson AD; Reddy ST; Sevanian A; Fonarow GC; Fogelman AM
J Lipid Res; 2000 Sep; 41(9):1495-508. PubMed ID: 10974057
[TBL] [Abstract][Full Text] [Related]
10. Adenovirus mediated expression of human paraoxonase 2 protects against the development of atherosclerosis in apolipoprotein E-deficient mice.
Ng CJ; Hama SY; Bourquard N; Navab M; Reddy ST
Mol Genet Metab; 2006 Dec; 89(4):368-73. PubMed ID: 16935014
[TBL] [Abstract][Full Text] [Related]
11. Serum paraoxonase is reduced in type 1 diabetic patients compared to non-diabetic, first degree relatives; influence on the ability of HDL to protect LDL from oxidation.
Boemi M; Leviev I; Sirolla C; Pieri C; Marra M; James RW
Atherosclerosis; 2001 Mar; 155(1):229-35. PubMed ID: 11223446
[TBL] [Abstract][Full Text] [Related]
12. Paraoxonase-2 deficiency aggravates atherosclerosis in mice despite lower apolipoprotein-B-containing lipoproteins: anti-atherogenic role for paraoxonase-2.
Ng CJ; Bourquard N; Grijalva V; Hama S; Shih DM; Navab M; Fogelman AM; Lusis AJ; Young S; Reddy ST
J Biol Chem; 2006 Oct; 281(40):29491-500. PubMed ID: 16891303
[TBL] [Abstract][Full Text] [Related]
13. Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio.
Navab M; Hama-Levy S; Van Lenten BJ; Fonarow GC; Cardinez CJ; Castellani LW; Brennan ML; Lusis AJ; Fogelman AM; La Du BN
J Clin Invest; 1997 Apr; 99(8):2005-19. PubMed ID: 9109446
[TBL] [Abstract][Full Text] [Related]
14. Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification.
Mackness B; Mackness MI; Arrol S; Turkie W; Durrington PN
FEBS Lett; 1998 Feb; 423(1):57-60. PubMed ID: 9506841
[TBL] [Abstract][Full Text] [Related]
15. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.
Aviram M; Rosenblat M; Bisgaier CL; Newton RS; Primo-Parmo SL; La Du BN
J Clin Invest; 1998 Apr; 101(8):1581-90. PubMed ID: 9541487
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the ability of paraoxonases 1 and 3 to attenuate the in vitro oxidation of low-density lipoprotein and reduce macrophage oxidative stress.
Liu Y; Mackness B; Mackness M
Free Radic Biol Med; 2008 Sep; 45(6):743-8. PubMed ID: 18585453
[TBL] [Abstract][Full Text] [Related]
17. Paraoxonase (PON1) deficiency is associated with increased macrophage oxidative stress: studies in PON1-knockout mice.
Rozenberg O; Rosenblat M; Coleman R; Shih DM; Aviram M
Free Radic Biol Med; 2003 Mar; 34(6):774-84. PubMed ID: 12633754
[TBL] [Abstract][Full Text] [Related]
18. Dietary antioxidants and paraoxonases against LDL oxidation and atherosclerosis development.
Aviram M; Kaplan M; Rosenblat M; Fuhrman B
Handb Exp Pharmacol; 2005; (170):263-300. PubMed ID: 16596803
[TBL] [Abstract][Full Text] [Related]
19. Review: The role of paraoxonase in cardiovascular diseases.
Kowalska K; Socha E; Milnerowicz H
Ann Clin Lab Sci; 2015; 45(2):226-33. PubMed ID: 25887882
[TBL] [Abstract][Full Text] [Related]
20. Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase.
Mackness MI; Arrol S; Abbott C; Durrington PN
Atherosclerosis; 1993 Dec; 104(1-2):129-35. PubMed ID: 8141836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
